Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program

OBJECTIVE: Weight management medications can significantly increase patients' chances of achieving a clinically meaningful weight loss if patients persist with treatment. This retrospective observational study of de‐identified medical records of 311 patients is the first real‐world study examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wharton, Sean, Haase, Christiane L, Kamran, Elham, Liu, Aiden, Mancini, Johanna, Neish, Drew, Pakseresht, Arash, Power, G Sarah, Christensen, Rebecca AG
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448157/
https://www.ncbi.nlm.nih.gov/pubmed/32874673
http://dx.doi.org/10.1002/osp4.419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448157/
https://www.ncbi.nlm.nih.gov/pubmed/32874673
http://dx.doi.org/10.1002/osp4.419

Ejemplares similares